Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Thromb Res. 2013 Nov 6;133(2):203–210. doi: 10.1016/j.thromres.2013.10.043

Fig. 3. Effect of ex vivo ASA, 2MeSAMP, MRS 2179 on final platelet aggregate size normalized by baseline platelet aggregate size formed over collagen.

Fig. 3

Ex vivo addition of ASA, 2MeSAMP, MRS 2179 resulted in smaller final platelet aggregate size compared to response measured with no drug (p < 0.01, n = 10 donors).